Markets & Regulations

(Image: Getty/Natali_Mis)

Digital tech exploded in 2018: Will 2019 see broad adoption?

By Melissa Fassbender

Awareness around the potential opportunities created by artificial intelligence has never been higher, but pharma’s biggest challenge in 2019 will be adopting and scaling the right technology to improve patient outcomes, says an industry executive.

(Image: Getty/AndreyPopov)

CRO industry still plagued by CRA turnover: Report

By Melissa Fassbender

Most CROs are struggling with employee retention, a challenge not new to the industry, which has seen turnover levels at or above 20% for seven of the last 10 years, according to a recent report.

How in silico trials are making personalized medicine a reality

How in silico trials are making personalized medicine a reality

By Melissa Fassbender

The biopharma industry is on the precipice of making personalized medicine a reality with access to massive amounts of data, computing power, and artificial intelligence to run in silico clinical trials, says GNS Healthcare CEO.

(Image: Getty/masterzphotois)

The biggest paradigm shift in decades? ICH E6 R2

By Melissa Fassbender

ICH E6 R2 sparked a paradigm shift, though 2019 will see the clinical trials industry transition from a risk-based monitoring approach to risk-based quality management.

Follow us


View more